Meridian Wealth Management LLC Purchases New Position in iShares Biotechnology ETF (NASDAQ:IBB)

Meridian Wealth Management LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 4,704 shares of the financial services provider’s stock, valued at approximately $685,000.

Several other large investors have also recently added to or reduced their stakes in the stock. Commerce Bank grew its stake in shares of iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after acquiring an additional 12,921 shares in the last quarter. Main Management ETF Advisors LLC grew its stake in shares of iShares Biotechnology ETF by 2.6% during the second quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock valued at $79,451,000 after acquiring an additional 14,535 shares in the last quarter. Raymond James Financial Services Advisors Inc. grew its stake in shares of iShares Biotechnology ETF by 24.6% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock valued at $29,792,000 after acquiring an additional 42,822 shares in the last quarter. Raymond James & Associates grew its stake in shares of iShares Biotechnology ETF by 4.4% during the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after acquiring an additional 7,931 shares in the last quarter. Finally, Albion Financial Group UT grew its stake in shares of iShares Biotechnology ETF by 0.3% during the third quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock valued at $18,925,000 after acquiring an additional 356 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $137.96 on Monday. The business has a 50-day moving average of $143.43 and a 200-day moving average of $141.87. iShares Biotechnology ETF has a 1-year low of $117.28 and a 1-year high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.